{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T20:33:56Z","timestamp":1778358836915,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"3-5","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.jsbmb.2006.12.065","type":"journal-article","created":{"date-parts":[[2007,1,23]],"date-time":"2007-01-23T07:58:18Z","timestamp":1169539098000},"page":"689-693","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Inhibition of prostate growth and inflammation by the vitamin D receptor agonist BXL-628 (elocalcitol)"],"prefix":"10.1016","volume":"103","author":[{"given":"Luciano","family":"Adorini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Penna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Amuchastegui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Cossetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Aquilano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedetta","family":"Fibbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annamaria","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milan","family":"Uskokovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Colli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2006.12.065_bib1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-3-642-55580-0_2","article-title":"Current understanding of the function of the nuclear vitamin D receptor in response to its natural and synthetic ligands","volume":"164","author":"Carlberg","year":"2003","journal-title":"Recent Results Cancer Res."},{"issue":"3","key":"10.1016\/j.jsbmb.2006.12.065_bib2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2174\/1389557033488204","article-title":"Vitamin D receptor as a drug discovery target","volume":"3","author":"Pinette","year":"2003","journal-title":"Mini Rev. Med. Chem."},{"issue":"5","key":"10.1016\/j.jsbmb.2006.12.065_bib3","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1210\/er.2004-0002","article-title":"Noncalcemic actions of vitamin D receptor ligands","volume":"26","author":"Nagpal","year":"2005","journal-title":"Endocr. Rev."},{"issue":"7","key":"10.1016\/j.jsbmb.2006.12.065_bib4","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S1567-5769(02)00049-8","article-title":"Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases","volume":"2","author":"Adorini","year":"2002","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jsbmb.2006.12.065_bib5","doi-asserted-by":"crossref","first-page":"1704S","DOI":"10.1093\/jn\/125.suppl_6.1704S","article-title":"Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions","volume":"125","author":"Lemire","year":"1995","journal-title":"J. Nutr."},{"issue":"2","key":"10.1016\/j.jsbmb.2006.12.065_bib6","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/1521-4141(200002)30:2<498::AID-IMMU498>3.0.CO;2-Q","article-title":"Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D(3)","volume":"30","author":"Mattner","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jsbmb.2006.12.065_bib7","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.1128\/MCB.15.10.5789","article-title":"Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition NFATp\/AP-1 complex formation by a nuclear hormone receptor","volume":"15","author":"Alroy","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.jsbmb.2006.12.065_bib8","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1002\/(SICI)1521-4141(199810)28:10<3017::AID-IMMU3017>3.0.CO;2-6","article-title":"Vitamin D3: a transcriptional modulator of the IFN-\u03b3 gene","volume":"28","author":"Cippitelli","year":"1998","journal-title":"Eur. J. Immunol."},{"issue":"9","key":"10.1016\/j.jsbmb.2006.12.065_bib9","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.4049\/jimmunol.167.9.4974","article-title":"1alpha,25-dihydroxyvitamin D3 has a direct effect on naive CD4(+) T Cells to enhance the development of Th2 cells","volume":"167","author":"Boonstra","year":"2001","journal-title":"J. Immunol."},{"issue":"1\u20135","key":"10.1016\/j.jsbmb.2006.12.065_bib10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jsbmb.2004.03.013","article-title":"Dendritic cells as key targets for immunomodulation by Vitamin D receptor ligands","volume":"89\u201390","author":"Adorini","year":"2004","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2006.12.065_bib11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1146\/annurev.nutr.23.011702.073114","article-title":"Vitamin D and its analogs as regulators of immune activation and antigen presentation","volume":"23","author":"Griffin","year":"2003","journal-title":"Annu Rev Nutr."},{"key":"10.1016\/j.jsbmb.2006.12.065_bib12","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.4049\/jimmunol.173.4.2280","article-title":"A Vitamin D analog downregulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development","volume":"173","author":"Giarratana","year":"2004","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.jsbmb.2006.12.065_bib13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cellimm.2005.04.013","article-title":"Intervention in autoimmunity: the potential of vitamin D receptor agonists","volume":"233","author":"Adorini","year":"2005","journal-title":"Cell Immunol."},{"issue":"10","key":"10.1016\/j.jsbmb.2006.12.065_bib14","first-page":"1458","article-title":"1,25-Dihydroxyvitamin D3 analogs as potential therapies in transplantation","volume":"3","author":"Adorini","year":"2002","journal-title":"Curr. Opin. Invest. Drugs"},{"issue":"8","key":"10.1016\/j.jsbmb.2006.12.065_bib15","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/00007890-200210270-00030","article-title":"Vitamin D as immunomodulatory therapy for kidney transplantation","volume":"74","author":"Becker","year":"2002","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.jsbmb.2006.12.065_bib16","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1210\/er.2004-0002","article-title":"Non-calcemic actions of vitamin D receptor ligands","volume":"26","author":"Nagpal","year":"2005","journal-title":"Endocr. Rev."},{"issue":"2","key":"10.1016\/j.jsbmb.2006.12.065_bib17","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1210\/jc.2004-1496","article-title":"Human bladder as a novel target for vitamin D receptor ligands","volume":"90","author":"Crescioli","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.jsbmb.2006.12.065_bib18","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1210\/en.2002-0210","article-title":"Inhibition of spontaneous and androgen-induced prostate growth by a nonhypercalcemic calcitriol analog","volume":"144","author":"Crescioli","year":"2003","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.jsbmb.2006.12.065_bib19","first-page":"805","article-title":"Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells","volume":"54","author":"Peehl","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2006.12.065_bib20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/978-3-642-55580-0_15","article-title":"The role of vitamin D in prostate cancer","volume":"164","author":"Krishnan","year":"2003","journal-title":"Recent Results Cancer Res."},{"issue":"6","key":"10.1016\/j.jsbmb.2006.12.065_bib21","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00432-006-0086-8","article-title":"The vitamin D analogue BXL-628 inhibits growth factor-stimulated proliferation and invasion of DU145 prostate cancer cells","volume":"132","author":"Marchiani","year":"2006","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.jsbmb.2006.12.065_bib22","first-page":"391","article-title":"Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3","volume":"7","author":"Schwartz","year":"1998","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"2","key":"10.1016\/j.jsbmb.2006.12.065_bib23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/jcb.10342","article-title":"Prostatic 25-hydroxyvitamin D-1alpha-hydroxylase and its implication in prostate cancer","volume":"88","author":"Chen","year":"2003","journal-title":"J. Cell Biochem."},{"issue":"7","key":"10.1016\/j.jsbmb.2006.12.065_bib24","first-page":"2576","article-title":"Effect of a vitamin D3 analogue on keratinocyte growth factor-induced cell proliferation in benign prostate hyperplasia","volume":"85","author":"Crescioli","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.jsbmb.2006.12.065_bib25","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1046\/j.1523-1755.2002.00450.x","article-title":"Update on vitamin D and its newer analogues: actions and rationale for treatment in chronic renal failure","volume":"62","author":"Malluche","year":"2002","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.jsbmb.2006.12.065_bib26","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1530\/eje.0.1500591","article-title":"Inhibition of prostate cell growth by BXL-628, a calcitriol analogue selected for a phase II clinical trial in patients with benign prostate hyperplasia","volume":"150","author":"Crescioli","year":"2004","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.jsbmb.2006.12.065_bib27","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eururo.2005.08.014","article-title":"BXL628, a novel vitamin D3 analog arrests prostate growth in patients with benign prostatic hyperplasia: a randomized clinical trial","volume":"49","author":"Colli","year":"2006","journal-title":"Eur. Urol."},{"issue":"9","key":"10.1016\/j.jsbmb.2006.12.065_bib28","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1046\/j.1464-410x.1999.00352.x","article-title":"Asymptomatic inflammation and\/or infection in benign prostatic hyperplasia","volume":"84","author":"Nickel","year":"1999","journal-title":"BJU Int."},{"issue":"5","key":"10.1016\/j.jsbmb.2006.12.065_bib29","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1159\/000020190","article-title":"Effect of inflammation and benign prostatic enlargement on total and percent free serum prostatic specific antigen","volume":"37","author":"Morote","year":"2000","journal-title":"Eur. Urol."},{"issue":"4","key":"10.1016\/j.jsbmb.2006.12.065_bib30","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1464-410X.2005.05341.x","article-title":"Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH","volume":"95","author":"Nickel","year":"2005","journal-title":"BJU Int."},{"issue":"1","key":"10.1016\/j.jsbmb.2006.12.065_bib31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/01.mou.0000193368.91823.1b","article-title":"Could inflammation be a key component in the progression of benign prostatic hyperplasia?","volume":"16","author":"Kramer","year":"2006","journal-title":"Curr. Opin. Urol."},{"issue":"5 Pt 1","key":"10.1016\/j.jsbmb.2006.12.065_bib32","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1097\/01.ju.0000133655.71782.14","article-title":"Molecular and cellular pathogenesis of benign prostatic hyperplasia","volume":"172","author":"Lee","year":"2004","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.jsbmb.2006.12.065_bib33","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0002-9440(10)64535-X","article-title":"Interleukin-1alpha is a paracrine inducer of FGF7, a key epithelial growth factor in benign prostatic hyperplasia","volume":"157","author":"Giri","year":"2000","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.jsbmb.2006.12.065_bib34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0002-9440(10)61681-1","article-title":"Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia","volume":"159","author":"Giri","year":"2001","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.jsbmb.2006.12.065_bib35","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/pros.10204","article-title":"Cellular senescence in the pathogenesis of benign prostatic hyperplasia","volume":"55","author":"Castro","year":"2003","journal-title":"Prostate"},{"issue":"4","key":"10.1016\/j.jsbmb.2006.12.065_bib36","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/pros.20261","article-title":"Interferon-gamma induces neuroendocrine-like differentiation of human prostate basal-epithelial cells","volume":"64","author":"Untergasser","year":"2005","journal-title":"Prostate"},{"issue":"3","key":"10.1016\/j.jsbmb.2006.12.065_bib37","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/01.ju.0000136002.76898.04","article-title":"Mechanisms in prostatitis\/chronic pelvic pain syndrome","volume":"172","author":"Pontari","year":"2004","journal-title":"J. Urol."},{"issue":"6","key":"10.1016\/j.jsbmb.2006.12.065_bib38","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1006\/jaut.1998.0248","article-title":"Non-obese diabetic (NOD) mice are genetically susceptible to experimental autoimmune prostatitis (EAP)","volume":"11","author":"Rivero","year":"1998","journal-title":"J. Autoimmun."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076006004420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076006004420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:58:11Z","timestamp":1760734691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076006004420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":38,"journal-issue":{"issue":"3-5","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0960076006004420"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2006.12.065","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of prostate growth and inflammation by the vitamin D receptor agonist BXL-628 (elocalcitol)","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2006.12.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}